We reach more than 65,000 active users in May!!

Releasing an immune system brake could help patients with rare but fatal brain infection: Small-scale, clinical study offers early hope for developing a treatment

The anti-cancer drug pembrolizumab has shown promise in slowing or stopping the progression of progressive multifocal leukoencephalopathy (PML), a typically fatal infection of the brain caused by the JC virus (JCV).

Leave a comment